Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A serologic marker for fetal risk of congenital heart block

Salomonsson, Stina, Dörner, Thomas, Theander, Elke, Bremme, Katarina, Larsson, Per, Wahren‐Herlenius, Marie · 2002 · Arthritis & Rheumatism

Abstract

Objective: To analyze the humoral immune response to Ro/SSA and La/SSB antigens in detail, in order to identify markers in mothers at high risk of having children with congenital heart block (CHB). Methods: Serum samples were obtained from 9 Ro/La‐positive mothers who gave birth to affected children, from their 8 newborns with CHB, and from 26 Ro/La‐positive mothers whose children were healthy. Antibodies against Ro 52‐kd, Ro 60‐kd, and La were analyzed by enzyme‐linked immunosorbent assay and immunoblotting, using recombinant proteins and synthetic peptides. Results: IgG anti‐Ro 52‐kd antibodies were detected in all mothers who gave birth to children with CHB, as well as in their affected children, but were less frequent and at lower levels in control mothers. Fine mapping revealed a striking difference in which the response in mothers with affected children was dominated by antibodies to amino acids 200–239 of the Ro 52‐kd protein (P = 0.0002), whereas the primary activity in control mothers was against amino acids 176–196 (P = 0.001). Furthermore, 8 of 9 mothers of children with CHB had antibody reactivity against amino acids 1–135 of the Ro 52‐kd protein, containing 2 putative zinc fingers reconstituted under reducing conditions. Conclusion: The results suggest that development of CHB is strongly dependent on a specific antibody profile to Ro 52‐kd, which may be a useful tool to identify pregnant Ro/La‐positive women at risk of delivering a baby with CHB. Close monitoring of mothers at high risk would enable early detection of a block that is still developing and allow early treatment to combat more serious complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.10232

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 159

Metadata

Authors
Salomonsson, S., Dörner, T., Theander, E., Bremme, K., Larsson, P., & Wahren‐Herlenius, M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2002-05
Volume
46
Issue
5
Pages
1233-1241
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2006681681
Cited by
159
References
1
FWCI
6.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A serologic marker for fetal risk of congenital heart block. https://app.cochat.ai/papers/10.1002/art.10232
The paper
Salomonsson, S., Dörner, T., Theander, E., Bremme, K., Larsson, P., & Wahren‐Herlenius, M. (2002). A serologic marker for fetal risk of congenital heart block. Arthritis & Rheumatism. https://doi.org/10.1002/art.10232

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.